AKR1C3 and neoplasm: After confirming that overexpression of AKR1C3 in HCT116 AKR1C3#6 did not modify the hypoxic fraction (Figure 6A), we used the new HCT116 AKR1C3#6 clone to investigate the relationship between PR-104 activity and tumour oxygenation status.